2003PubMedRequires access

Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy.

T. Pawiński, Leslie M. Shaw

Open publisher page 8 citations

Abstract

The aim of this study was to investigate the stability of mycophenolic acid (MPA) in human plasma from patients receiving mycophenolate mofetil (MMF) therapy. MPA was measured using a validated HPLC method. MPA concentrations were determined immediately after receiving the samples in the laboratory, and after 24 h, 72 h, 96 h, 7, 14, 21 days of storage at two different temperatures at -20 degrees C and 4 degrees C. The number of samples used in different conditions of temperature was limited by plasma volume in patients specimens. Monitoring human plasma samples stored at -20 degrees C showed that MPA was stable at this temperature for at least 3 weeks. MPA concentrations were found to be stable also up to 96 hours when stored at 4 degrees C.

About this research paper

What this paper is about

The aim of this study was to investigate the stability of mycophenolic acid (MPA) in human plasma from patients receiving mycophenolate mofetil (MMF) therapy. MPA was measured using a validated HPLC method. MPA concentrations were determined immediately after receiving the samples in the laboratory, and after 24 h, 72 h, 96 h, 7, 14, 21 days of storage at two different temperatures at -20 degrees C and 4 degrees C. The number of samples used in different conditions of temperature was limited by plasma volume in patients specimens. Monitoring human plasma samples stored at -20 degrees C showed that MPA was stable at this temperature for at least 3 weeks. MPA concentrations were found to be stable also up to 96 hours when stored at 4 degrees C.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The aim of this study was to investigate the stability of mycophenolic acid (MPA) in human plasma from patients receiving mycophenolate mofetil (MMF) therapy. MPA was measured using a validated HPLC method. MPA concentrations were determined immediately after receiving the samples in the laboratory, and after 24 h, 72 h, 96 h, 7, 14, 21 days of storage at two different temperatures at -20 degrees C and 4 degrees C. The number of samples used in different conditions of temperature was limited by plasma volume in patients specimens. Monitoring human plasma samples stored at -20 degrees C showed that MPA was stable at this temperature for at least 3 weeks. MPA concentrations were found to be stable also up to 96 hours when stored at 4 degrees C.

Key concepts: Mycophenolate, Mycophenolic acid, Chromatography, Chemistry, Plasma concentration, Human plasma, High-performance liquid chromatography, Chemical stability

Related papers

Back to paper searchBrowse research topicsOriginal source
Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy. — Research Paper | ScholarLens